SCHEMBL27699892

SCHEMBL27699892

CS(=O)(=O)c1[c]cccc1CN

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.32
LOX P28300 2/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414041 0.75 CYP3A4 (0.36)
SCHEMBL15415279 0.72 KEAP1 (0.34)
SCHEMBL3057169 0.72 HSD11B1 (0.33) LOX
SCHEMBL11567025 0.71 CA1 (0.34)
SCHEMBL1828766 0.71 HSD11B1 (0.33)
SCHEMBL1116655 0.71 ALDH1A1 (0.33)
SCHEMBL29792680 0.68 LOX (0.49) PNMTLOXDPP4
SCHEMBL1146006 0.68 LOX (0.49) PNMTLOXDPP4
SCHEMBL5259290 0.68 L3MBTL1 (0.42)
SCHEMBL5152547 0.68 GABRA1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128439-A 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis GLAXO GROUP LTD (GB) 2008-02-20 CN disclosed